Loss of E-Cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: Possible implication in the enhanced invasive ability

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 9, 2012, Pages 1271-1279

  Lu, L ^a   Zhou, D ^a   Jiang, X ^a   Song, K ^b   Li, K ^c   Ding, W ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b United Family Healthcare   (China)

^c SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Drug resistance; E Cadherin; Invasion metastasis; MCF 7 cells

Indexed keywords

ACTIN; CATENIN; UVOMORULIN;

ARTICLE; BREAST CANCER; CELL JUNCTION; CELL MOTILITY; CELL NUCLEUS; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSKELETON; DESMOSOME; ELECTRON MICROSCOPY; IMMUNOCYTOCHEMISTRY; MICROSCOPY; MULTIDRUG RESISTANCE; PHENOTYPE; PROTEIN EXPRESSION; WESTERN BLOTTING;

BREAST NEOPLASMS; CADHERINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MCF-7 CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM INVASIVENESS;

EID: 84867936591     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. BEHRENS J. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev 1999; 18: 15-30.
2. TAKEICHI M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
3. CHEN ST, PAN TL, TSAI YC, HUANG CM. Proteomics reveals protein profile changes in doxorubicin-Treated MCF-7 human breast cancer cells. Cancer Lett 2002; 181: 95-107.
4. ALBINI A, BENELLI R, NOONAN DM, BRIGATI C. The "chemoinvasion assay": A tool to study tumor and endothelial cell invasion of basement membranes. Int J Devel Biol 2004; 48: 563-571.
5. FAUTE MAD, LAURENT L, PLOTON D, POUPON MF, JARDILLIER JC, BOBICHON H. Distinctive alterations of invasiveness, drug resistance and cell-Cell organization in 3D-Cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant, . Clin Exp Metastasis 2002; 19: 161-168.
6. LIANG Y, MCDONNELL S, CLYNES M. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002; 2: 257-277.
7. HAGA A, NAGASE H, KITO H, SATO T. Invasive properties of cadmium-Resistant human fibrosarcoma HT-1080 cells. Cancer Biochem Biophys 1997; 15: 275-284.
8. LIANG Y, MELEADY P, CLEARY I, MCDONNELL S, CONNOLLY L, CLYNES M. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur J Cancer 2001; 37: 1041-1052.
9. YANG JM, VASSIL A, HAIT WN. Involvement of phosphatidylinositol-3-Kinase in membrane ruffling induced by P-Glycoprotein substrates in multidrugresistant carcinoma cells. Biochem Pharmacol 2002; 63: 959-966.
10. WONG AS, GUMBINER BM. Adhesion-Independent mechanism for suppression of tumor cell invasion by E-Cadherin. J Cell Biol 2003; 161: 1191-1203.
11. MAYER B, JOHNSON JP, LEITL F, JAUCH KW, HEISS MM, SCHILDBERG FW, BIRCHMEIER W, FUNKE I. E-Cadherin expression in primary and metastatic gastric cancer: Down-Regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695.
12. BECKER KF, KREMMER E, EULITZ M, BECKER I, HANDSCHUH G, SCHUHMACHER C, MULLER W, GABBERT HE, OCHIAI A, HIROHASHI S, HOFLER H. Analysis of Ecadherin in diffuse-Type gastric cancer using a mutation-Specific monoclonal antibody. Am J Pathol 1999; 155: 1803-1809.
13. HANDSCHUH G, LUBER B, HUTZLER P, HOFLER H, BECKER KF. Single amino acid substitutions in conserved extracellular domains of E-Cadherin differ in their functional consequences, J Mol Biol 2001; 314: 445-454.
14. BECKER KF, KREMMER E, EULITZ M, SCHULZ S, MAGES J, HANDSCHUH G, WHEELOCK MJ, CLETON-JANSEN AM, HOFLER H, BECKER I. Functional allelic loss detected at the protein level in archival human tumours using allele-Specific E-Cadherin monoclonal antibodies. J Pathol 2002; 197: 567-574.
15. HUMAR B, GUILFORD P. Hereditary diffuse gastric cancer: A manifestation of lost cell polarity. Cancer Sci 2009; 100: 1151-1157.
16. ROWLANDS TM, SYMONDS JM, FAROOKHI R, BLASCHUK OW. Cadherins: Crucial regulators of structure and function in reproductive tissues. Rev Reprod 2000; 5: 53-61.
17. TSANOU E, PESCHOS D. The E-Cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 2008; 28: 3815-3826.
18. OLSON M, SAHAI E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009; 26: 273-287.
19. CHAND A, HERRIDGE K, THOMPSON E, CLYNE C. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer 2010; 17: 965-975.
20. CONACCI-SORRELL M, ZHURINSKY J, BEN-ZÉEV A. The cadherin-Catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-991.
21. MAREEL M, BOTERBERG T, NOE V, VAN HOORDE L, VERMEULEN S, BRUYNEEL E, BRACKE M. E-Cadherin/ catenin/cytoskeleton complex: A regulator of cancer invasion. J Cell Physiol 1997; 173: 271-274.
22. JIANG WG. E-Cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 1996; 83: 437-446.
23. CHARLIER C, BRUYNEEL E, LECHANTEUR C, BRACKE M, MAREEL M, CASTRONOVO V. Enhancement of tamoxifen-Induced E-Cadherin function by Ca2+ channel antagonists in human breast cancer MCF7/6 cells. Eur J Pharmacol 1996; 317: 413-416.
24. BYERS SW, SOMMERS CL, HOXTER B, MERCURIO AM, TOZEREN A. Role of E-Cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: Measurement of cell-Cell adhesion strength. J Cell Sci 1995; 108 (Pt 5): 2053-2064.
25. MADER C, OSER M. An EGFR-Src-Arg-Cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 2011; 71: 1730-1741.
26. YAMAGUCHI H, OIKAWA T. Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis. Oncotarget 2010 1: 320-328.
27. TANNOCK IF. Tumor physiology and drug resistance. Cancer Metastasis Rev 2001; 20: 123-132.
28. WOLF-YADLIN A, KUMAR N, ZHANG Y, HAUTANIEMI S, ZAMAN M, KIM HD, GRANTCHAROVA V, LAUFFENBURGER DA, WHITE FM. Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Sys Biol 2006.
29. LI Y, YUAN H. The structure and functions of P-Glycoprotein. Curr Med Chem 2010; 17: 786-800.
30. YANG JM, XU Z, WU H, ZHU H, WU X, HAIT WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1: 420-427.
31. YANG SZ, KOHNO N, KONDO K, YOKOYAMA A, HAMADA H, HIWADA K, MIYAKE M. Adriamycin activates Ecadherin-Mediated cell-Cell adhesion in human breast cancer cells. Int J Oncol 1999; 15: 1109-1115.
32. WEINSTEIN RS, HANSEN KK, MCBEATH RB, DALTON WS. Expression of the MDR1 gene (P-Glycoprotein) in breast cancer. Rec Res Cancer Res 1993; 127: 49-54.
33. MEACHAM W, ANTOON J, BUROW M, STRUCKHOFF A, BECKMAN B. Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Exp Biol Med 2009; 234: 1253-1263.
34. WIJNHOVEN BPL, DINJENS WNM, PIGNATELLI M. Ecadherin-Catenin cell-Cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005.
35. FRIXEN UH, BEHRENS J, SACHS M, EBERLE G, VOSS B, WARDA A, LOCHNER D, BIRCHMEIER W. E-Cadherinmediated cell-Cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
36. ROGER L, JULLIEN L, GIRE V, ROUX P. Gain of oncogenic function of p53 mutants regulates E-Cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci 2010; 123: 1295-1305.